Funding Opportunity: Genomics Technology Platforms – Operations Support and Technology Development Funds
July 25, 2016
July 20, 2016, Ottawa, ON – Genome Canada funds and manages large-scale, milestone-driven genomics research projects across multiple sectors of importance to Canada including health, agriculture and agri-food, forestry, fisheries and aquaculture, the environment, energy and mining. Genome Canada’s mission also includes a commitment to provide researchers across Canada access to leading-edge genomic technologies, whether their projects are funded by Genome Canada or other organizations. Genome Canada fulfils this part of its mandate by supporting a number of genomics technology platforms across Canada.
Each technology platform provides researchers access to high throughput genomic technologies such as DNA sequencing, RNA expression, protein identification and quantitation, and metabolomics, as well as new method and protocol development, data analysis and bioinformatics. Each platform also assists researchers in the development of research proposals by providing advice on appropriate technologies, study design, data analysis and bioinformatics that improves the quality of the research. The platforms also develop new and improved genomic technologies ensuring that the services they provide are able to support cutting-edge genomics research.
Today, Genome Canada launches a new competition: Genomics Technology Platforms – Operations Support and Technology Development Funds. This funding opportunity has two main objectives:
2. To enable the selected platforms to develop new technologies and/or improve existing technologies that will improve services provided by the platform and will ensure that they remain at the forefront in providing access to leading edge genomics technologies and methods.
This is an open competition and applicants are to submit a request for both operations support and technology development for a term of five years. There is a maximum total envelope of $15 million per year available from Genome Canada. The last two years of funding are subject to the successful outcome of an interim review for each platform and Genome Canada securing additional funding. The maximum available funds from Genome Canada for each successful platform will be $2 million per year over five years. At least 50 per cent of the funds requested and awarded must be for operations support on an annual basis. In addition, applicants will be required to demonstrate that financing from co-funders of an amount at least equal to the amount requested from Genome Canada is also available to the platform. For further details on co-funding, please refer to the Guidelines for Funding Research Projects and Appendix C.